Revolution Medicines Inc (RVMD)
37.56 x 1 44.00 x 2
Post-market by (Cboe BZX)
36.76 +0.56 (+1.55%) 04/17/25 [NASDAQ]
37.56 x 1 44.00 x 2
Post-market 37.50 +0.74 (+2.01%) 16:51 ET
for Thu, Apr 17th, 2025
Results
download Want to compare other data? Select Fields| Symbol | RVMD | ROIV | JAZZ | ||
| Company | Revolution Medicines Inc | Roivant Sciences Ltd | Jazz Pharma Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 36.06 | 10.05 | 101.37 | ||
| High | 36.87 | 10.22 | 104.53 | ||
| Low | 35.82 | 10.01 | 100.54 | ||
| Last | 36.76 | 10.15 | 102.78 | ||
| Change | +0.56 | +0.13 | +1.23 | ||
| % Change | +1.55% | +1.30% | +1.21% | ||
| Volume | 1,274,800 | 2,625,400 | 995,200 | ||
| 20-Day Average Volume | 1,985,135 | 7,971,595 | 1,619,080 | ||
| Previous Close | 36.20 | 10.02 | 101.55 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 35.48 | 10.06 | 116.70 | ||
| 20-Day Raw Stochastic | 72.84% | 63.11% | 15.46% | ||
| 20-Day Relative Strength | 48.90% | 48.25% | 33.71% | ||
| Weighted Alpha | -7.90 | -8.61 | -13.93 | ||
| Today's Opinion | 88% Sell | 88% Sell | 40% Sell | ||
| Previous Opinion | 88% Sell | 100% Sell | 24% Sell | ||
| Last Month's Opinion | 88% Sell | 48% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.18% since 04/10/25 | +5.18% since 04/10/25 | +0.72% since 04/10/25 | ||
| Low | 33.25 on 04/11/25 | 9.57 on 04/11/25 | 98.59 on 04/11/25 | ||
| High | 36.87 on 04/17/25 | 10.26 on 04/14/25 | 104.53 on 04/17/25 | ||
| 1-Month | |||||
| %Chg | -6.06% since 03/17/25 | -6.45% since 03/17/25 | -26.70% since 03/17/25 | ||
| Low | 29.17 on 04/07/25 | 8.73 on 04/07/25 | 95.49 on 04/09/25 | ||
| High | 39.59 on 03/24/25 | 11.41 on 03/19/25 | 142.64 on 03/24/25 | ||
| 3-Month | |||||
| %Chg | -8.76% since 01/17/25 | -8.97% since 01/17/25 | -15.18% since 01/17/25 | ||
| Low | 29.17 on 04/07/25 | 8.73 on 04/07/25 | 95.49 on 04/09/25 | ||
| High | 44.68 on 02/05/25 | 11.51 on 02/10/25 | 148.06 on 02/26/25 | ||
| 6-Month | |||||
| %Chg | -26.48% since 10/17/24 | -14.78% since 10/17/24 | -10.34% since 10/17/24 | ||
| Low | 29.17 on 04/07/25 | 8.73 on 04/07/25 | 95.49 on 04/09/25 | ||
| High | 62.40 on 11/11/24 | 12.94 on 11/25/24 | 148.06 on 02/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,834,161 | 7,242,523 | 6,242,034 | ||
| Shares Outstanding, K | 185,913 | 713,549 | 60,732 | ||
| Annual Sales | 0 | 124,800,000 | 4,068,950,000 | ||
| Annual Net Income | -600,090,000 | 4,348,930,000 | 560,120,000 | ||
| Last Quarter Sales | 0 | 9,020,000 | 1,088,170,000 | ||
| Last Quarter Net Income | -194,570,000 | 169,380,000 | 191,120,000 | ||
| 60-Month Beta | 1.37 | 1.25 | 0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.12 on 02/26/25 | -0.13 on 02/10/25 | 6.60 on 02/25/25 | ||
| Latest Earnings Date | 05/14/25 | 05/29/25 | 05/07/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 5.58 | ||